Concepedia

Author

A Matano

Fondazione Santa Lucia

Also Known As

A MATANO, A Matano, A. M. R. Matano, A. M. Rita Matano, A. Matano, A.M.R. Matano, Alessandra Matano, Alfredo Matano

13

Publications

291

Citations

8

H-Index

21

Concepts

All Affiliations

Fondazione Santa LuciaIstituti di Ricovero e Cura a Carattere ScientificoSapienza University of RomeArcispedale Sant'Anna
AM

About

A Matano is an author at Fondazione Santa Lucia specializing in medicine, tumor biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

91

2

Social Sciences

1

1

60

3

Cell Biology

1

1

11

4

Neurology

1

1

60

5

Neuroscience

1

1

60

A Matano

×

8

Publications

282

Citations

8

H-Index

YearCitations

Impact of participation on rehabilitation results: a multivariate study.

Stefano Paolucci, Antonella Di Vita, Roberta Massicci,

PubMed

2012

83

Patterns of Attentional Impairment Following Closed Head Injury: A Collaborative European study

Pierluigi Zoccolotti, A Matano, Gérard Deloche,

Cortex

2000

60

Quality of life improved by multidisciplinary back school program in patıents with chronic non-specific low back pain: a single blind randomized controlled trial.

Giovanni Morone, Teresa Paolucci, Maria Rosaria Alcuri,

PubMed

2011

53

Psychological features and outcomes of the Back School treatment in patients with chronic non-specific low back pain. A randomized controlled study.

Teresa Paolucci, Giovanni Morone, Marco Iosa,

PubMed

2012

24

3300 A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma

C. van Herpen, Michael A. Postow, Matteo S. Carlino,

European Journal of Cancer

2015

20

Does outcome of neuropsychological treatment in patients with unilateral spatial neglect after stroke affect functional outcome?

A Matano, Marco Iosa, Cecilia Guariglia,

PubMed

2015

19

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

Stefania Capone, Francesco Maria Fusco, Stefano Milleri,

Cell Reports Medicine

2023

12

Phase I Study of Lee011 (Cdk4/6 Inhibitor) in Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Cyclin D–Cdk4/6 Pathway-Activated Tumors

Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois,

Annals of Oncology

2014

11

Page 1